Stakeholders’ perspectives on a patient-reported outcome measure-based drug safety monitoring system for immune-mediated inflammatory diseases

  • Leanne J. Kosse (Creator)
  • Naomi T. Jessurun (Creator)
  • Harald E. Vonkeman (Creator)
  • Sander Tas (Creator)
  • Mike T. Nurmohamed (Creator)
  • Frank Hoentjen (Creator)
  • Martijn B. A. van Doorn (Contributor)
  • Eugène P. van Puijenbroek (Contributor)
  • Bart J. F. van den Bemt (Contributor)
  • Marieke de Vries (Contributor)
  • Bart J. F. van den Bemt (Creator)

Dataset

Description

Biologics are used as effective therapeutics to treat a variety of diseases. Even though biologics are widely used, knowledge on the post-marketing experience of patients is limited. Therefore, a framework was established for a patient-reported outcome ...
Date made available2020
PublisherTaylor & Francis

Access Dataset

Cite this